What does the evidence say about Safflower Oil Blood Pressure Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Safflower Oil Blood Pressure Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - This systematic review and meta-analysis evaluated the impact of VCO on key cardiometabolic risk factors in adults. [Zhang Y (2025); evidence level 1] - Pooled analyses showed that VCO significantly reduced triglycerides (WMD: - 12.12 mg/dL; 95% CI: - 23.14 to - 1.09) and increased high density lipoprotein-cholesterol (HDL-C) (WMD: 7.91 mg/dL; 95% CI: 4.41 to 11.40). [Zhang Y (2025); evidence level 1] - Assessment of publication bias using funnel plots and Egger's test indicated no significant evidence of bias. [Zhang Y (2025); evidence level 1] - Background Cardiometabolic disorders remain a leading cause of morbidity and mortality worldwide. [Zhang Y (2025); evidence level 1] - Increased dietary LA has contributed to a pervasive imbalance in dietary-6 relative to-3 polyunsaturated fatty acids (PUFA) that has been proposed to affect the incidence and progression of chronic diseases [,,]. [Sergeant Susan (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.